BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 23.60
+0.20 (0.85%)
At close: Feb 19, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 138.01 million as of February 20, 2026.
Market Cap
138.01M
Enterprise Value
64.19M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.60
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 138.01M, a decrease of -33.62%. That is a compound annual growth rate of -32.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 138.01M | -3.28% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 998.48M |
| Basilea Pharmaceutica AG | 663.56M |
| Newron Pharmaceuticals | 420.31M |
| Santhera Pharmaceuticals Holding AG | 237.59M |
| Molecular Partners AG | 135.38M |
| Xlife Sciences AG | 125.73M |
| EvoNext Holdings | 6.23M |
| Addex Therapeutics | 5.67M |